Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Bristol Myers drops cell therapy pacts with Immatics, Century as part of portfolio review
5 months ago
Deals
R&D
Roche terminates a Phase 3 Spark gene therapy in hemophilia A
5 months ago
R&D
Cell/Gene Tx
The Endpoints 100 is back; Inside Isomorphic Labs; FDA adcomm discusses severe RSV cases; and more
5 months ago
Weekly
FTC OKs Novo-Catalent deal in major win for Novo Nordisk’s GLP-1 manufacturing
5 months ago
Deals
Manufacturing
Organon's steroid-free cream Vtama wins approval in atopic dermatitis
5 months ago
Pharma
FDA+
McKinsey hit with a $650M fine for deceiving US about opioid consulting work
5 months ago
Pharma
Law
FDA stands by mifepristone safety label in federal court challenge
5 months ago
Pharma
FDA+
Bicycle Therapeutics stock sinks following release of topline data, post-hoc analyses
5 months ago
R&D
Pharma
EMA's committee says expanded label for Lilly's Mounjaro into sleep apnea not necessary
5 months ago
Pharma
FDA+
Boundless shares dip as it nixes cancer asset, reshuffles execs
5 months ago
People
R&D
BeiGene licenses solid tumor drug, matches with Ideaya’s combo plans
5 months ago
Deals
R&D
CDK4 inhibitors from BeiGene and Pfizer, ALX’s CD47 drug take the stage at SABCS
5 months ago
R&D
Pharma
Repare plans for Phase 3 endometrial cancer study, sidelining ovarian cancer
5 months ago
R&D
Eisai subsidiary nabs Japan rights for schizophrenia drug; Novavax's $50M milestone
5 months ago
News Briefing
AbbVie makes another small I&I acquisition, buying Nimble for $200M
5 months ago
Startups
Deals
Xaira hires former Roche exec as CMO; 'Tis the season for retirements at Alnylam, Regeneron
5 months ago
People
Peer Review
After poor lung cancer data, iTeos drops inupadenant to double down on TIGIT
5 months ago
R&D
Gilead names Dietmar Berger CMO as it eyes R&D reset
5 months ago
People
Editas to cut 65% of workforce, officially stops work on ex vivo sickle cell therapy
5 months ago
R&D
Cell/Gene Tx
Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm
5 months ago
R&D
Pharma
'Serious liver injury' cases lead FDA to call for monitoring of Ocaliva patients
5 months ago
Pharma
FDA+
Handful of 'unsupported' drug price increases added $800M to US costs, ICER claims
5 months ago
Pharma
Padlock shareholders sue Bristol Myers over milestone dispute after 2016 acquisition
5 months ago
Deals
Pharma
Elevation to pay up to $368M in ADC deal; Bavarian Nordic closes San Diego site
5 months ago
News Briefing
First page
Previous page
64
65
66
67
68
69
70
Next page
Last page